Dr. Lubbertus C. Mulder's lab focuses on understanding how drug use affects HIV latency, particularly in the brain's immune cells called microglia. The team is investigating a group of viruses known as human endogenous retroviruses (HERVs) and how they interact with HIV. Their goal is to find new markers for HIV latency and to see how these relationships can be influenced by narcotic use.

Dr. Michael Bukrinsky's lab focuses on understanding how HIV infection affects the brain, particularly in relation to neurological disorders that arise despite effective anti-retroviral treatments. They are investigating the role of a protein called Nef in disrupting cholesterol metabolism in neurons, which may contribute to cognitive impairments experienced by individuals living with HIV. The ultimate goal is to identify potential therapeutic strategies to mitigate these neurological issues and enhance the quality of life for affected patients.

Dr. Joao Filipe Inacio Mamede's lab studies HIV and its effects on the brain, particularly focusing on how HIV and substance abuse, like Methamphetamine, trigger neuroinflammation and cognitive disorders. They explore the cellular interactions and molecular pathways involved in these processes, aiming to uncover new therapeutic targets to improve the health of individuals living with HIV/AIDS. Through advanced techniques, the lab seeks to better understand brain responses in people who experience these conditions despite current treatments.

Dr. Ya-Chi Ho's lab at Yale University focuses on understanding how HIV-1 persists in the immune system, specifically in CD4+ T cells, which are critical for immune defense. Despite treatment, HIV-1 infected cells can survive and even proliferate, making it difficult to completely eliminate the virus. The lab uses advanced single-cell technologies to investigate the mechanisms behind HIV-1 persistence and how these infected cells evade immune responses, aiming to identify better therapeutic targets for HIV treatments.

Dr. Michael Betts' lab focuses on understanding the mechanisms that allow HIV to persist in infected individuals, which is crucial for developing effective cure strategies. They utilize advanced techniques to analyze the immune response and the characteristics of the HIV reservoir, with the aim of enhancing treatments for people living with HIV. The research seeks to identify potential therapeutic targets to improve immune responses and reduce the viral reservoir in patients.

Dr. Li Wu's lab at the University of Iowa focuses on developing new strategies for treating HIV/AIDS by studying how the virus interacts with human immune cells. The main research involves exploring the role of specific RNA modifications in HIV-1, understanding the mechanisms that help the virus persist despite treatment, and investigating how host proteins can influence the immune response to HIV. Their work aims to uncover fundamental insights that could lead to more effective therapies for HIV infection.

Dr. Sarah Beth Joseph's lab focuses on understanding how certain HIV-infected cells manage to survive in the body despite the immune system's efforts to eliminate them. By examining the differences between 'early' and 'late' infection reservoir cells, they aim to discover why some cells resist clearance and how to enhance the immune response against them. Their work could lead to better strategies for curing HIV infections through improved identification and targeting of these resilient cells.

Dr. Hillel Haim's lab focuses on understanding how HIV-1 can develop resistance to therapeutic treatments. The research aims to personalize medicine for HIV patients by predicting which viruses are likely to escape treatment. By studying the virus's genetic properties and how they change over time, the lab works towards developing strategies for more effective antiviral therapies.

Dr. Zandrea Ambrose's lab at the University of Pittsburgh focuses on understanding how HIV-1, the virus responsible for AIDS, develops resistance to a new type of antiviral drug called lenacapavir. By studying these resistance pathways both in test tubes and in specially designed mouse models, the lab aims to uncover how these resistant viruses may impact treatment and prevention strategies. This research is crucial for improving HIV therapies and understanding how drug resistance can affect public health.

Dr. Alexander Hoffmann's lab at UCLA focuses on understanding how macrophages, which are crucial immune cells, respond to different stimuli and pathogens. The lab studies the mechanisms behind macrophage immune training, which is when past exposures reshape their future responses. By analyzing how these cells undergo epigenomic changes and how different transcription factors like IRFs shape their behavior, the lab aims to uncover insights that could inform treatments for infectious and inflammatory diseases.

Dr. Pingping Hou's lab focuses on innovating cancer therapies specifically for pancreatic cancer, one of the deadliest forms of cancer. The lab is developing a unique treatment method that combines genetically modified macrophages with targeted cancer treatments to improve outcomes for patients. This research aims to enhance the effectiveness of these therapies while minimizing potential side effects.

Dr. Hui Hu's research lab at the University of Alabama at Birmingham focuses on understanding how CD4+ T cells, which are crucial for our immune responses, differentiate into various types, including memory cells. This lab studies the complex genetic and molecular processes that govern these cells' development, especially how they form during initial immune responses and later evolve into specialized types that help fight infections. Their work has significant implications for vaccine development and the treatment of immune-related diseases.

Dr. Anna Huttenlocher's lab at the University of Wisconsin-Madison studies how cells move and communicate during the healing of wounds. They primarily use zebrafish as a model organism because of their clear bodies, which allow researchers to observe cellular interactions easily. The lab aims to understand the molecular mechanisms that regulate cell migration, which is crucial for repairing tissues and can provide insights into conditions like diabetes and autoimmune diseases.

Dr. Joseph M. Hyser's lab at Baylor College of Medicine studies how viruses, particularly rotavirus, manipulate calcium signaling pathways in host cells to enhance their replication and spread. The lab focuses on understanding the mechanisms behind rotavirus-induced calcium signals, exploring both the viral strategies that exploit these pathways and the host's physiological responses. This research could pave the way for new antiviral therapies by identifying key cellular interactions involved in virus-host dynamics.

Dr. John J. Iacomini's lab at Tufts University focuses on understanding how microRNAs regulate gene expression and influence kidney transplant rejection. By studying these small RNA molecules, the lab aims to uncover the mechanisms behind chronic antibody-mediated rejection, which is a leading cause of transplant failure. Their research involves a combination of advanced techniques to map interactions between microRNAs and their target mRNAs, providing insights that could improve the success rates of kidney transplants.

Dr. Carolyn Brook Ibberson's lab at the University of Tennessee Knoxville explores the interactions between different types of microbes in environments such as chronic wounds. The lab aims to understand how these microbial communities work together or compete with one another at a molecular level, which is crucial for human health. By mapping out the spatial and metabolic landscapes of these communities, the lab seeks to identify new strategies to promote healthier microbial interactions.

Dr. Ruslan Medzhitov's lab at Yale University studies Immunoglobulin E (IgE), a type of antibody that plays a crucial role in the immune response. While IgE is well-known for causing allergies, the lab is interested in understanding its functions in maintaining health and fighting diseases. They aim to identify specific antigens that IgE responds to and how these interactions influence the body's response during infections and inflammation.

Dr. Minsoo Kim's lab explores how immune cells interact with other tissues in the body, particularly focusing on T cells, which are crucial for fighting infections and cancer. They study how these cells can be directed to target tissues without causing harmful side effects, especially in therapies like CAR-T cell treatment. Additionally, the lab investigates how certain immune cells promote the formation of long-lasting memory T cells that can quickly respond to infections, and how these processes are impacted during severe conditions like sepsis.

Dr. Dario Aa Vignali's lab at the University of Pittsburgh focuses on understanding the complex mechanisms that regulate immunity, particularly in cancer and autoimmune diseases. They study proteins like LAG3 that inhibit T cell activity, exploring how these proteins can be targeted to improve cancer immunotherapy and manage autoimmune disorders. Their research aims to discover new ways to enhance immune responses against tumors while minimizing harmful effects on healthy cells.

Dr. Gene Garrard Olinger's lab at the University of Texas Medical Branch focuses on maintaining and optimizing the Galveston National Laboratory, a high-containment facility dedicated to studying infectious diseases. The lab provides unique resources for researchers to develop therapeutics, diagnostics, and vaccines for dangerous pathogens, while also training the next generation of experts in global health. Through rapid response capabilities, the lab plays a critical role in addressing public health emergencies and bioterrorism threats.